I1DX34:BVMF
Idexx Laboratories Inc Bdr
516,36Â BRL
0,00%
(0,00) 1Â D
9. okt., 16:56:00 GMT-3 · BRL
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for I1DX34 …
Ã…pne
516,36Â BRL
Høy
516,36Â BRL
Lav
516,36Â BRL
Markedsverdi
41,28Â mrd.
Snittvolum
6,00
Volum
5,00
52 u høy
813,60Â BRL
52Â u lav
509,99Â BRL
Utestående aksjer
78,78Â mill.
Antall ansatte
11k
Ã…pne
516,36Â BRL
Høy
516,36Â BRL
Lav
516,36Â BRL
Markedsverdi
41,28Â mrd.
Snittvolum
6,00
Volum
5,00
52 u høy
813,60Â BRL
52Â u lav
509,99Â BRL
Utestående aksjer
78,78Â mill.
Antall ansatte
11k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Investing.com
·
for 23 timer siden
KeyBanc initiates Idexx Laboratories stock rating at Sector Weight
Profil
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
Om Idexx Laboratories Inc Bdr
Administrerende direktørJay Mazelsky
Ansatte11k
Grunnlagt19. des. 1983
HovedkontorWestbrook, Maine, USA
Sektor-
Nettstedidexx.com